Found: 17
Select item for more details and to access through your institution.
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00224-0
- By:
- Publication type:
- Article
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071146
- By:
- Publication type:
- Article
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 289, doi. 10.3390/vaccines8020289
- By:
- Publication type:
- Article
Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasis.
- Published in:
- Parasite Immunology, 2022, v. 44, n. 8, p. 1, doi. 10.1111/pim.12921
- By:
- Publication type:
- Article
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
- Published in:
- Parasite Immunology, 2020, v. 42, n. 12, p. 1, doi. 10.1111/pim.12784
- By:
- Publication type:
- Article
In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis.
- Published in:
- Parasite (1252607X), 2021, v. 28, p. 1, doi. 10.1051/parasite/2021036
- By:
- Publication type:
- Article
A clioquinol-containing Pluronic<sup>®</sup> F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model.
- Published in:
- Parasite (1252607X), 2020, v. 27, p. 1, doi. 10.1051/parasite/2020027
- By:
- Publication type:
- Article
Leishmania infantum β-Tubulin Identified by Reverse Engineering Technology through Phage Display Applied as Theranostic Marker for Human Visceral Leishmaniasis.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 8, p. 1812, doi. 10.3390/ijms20081812
- By:
- Publication type:
- Article
Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 1, p. 129, doi. 10.3390/ijms19010129
- By:
- Publication type:
- Article
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
- Published in:
- Parasitology Research, 2023, v. 122, n. 12, p. 2917, doi. 10.1007/s00436-023-07981-6
- By:
- Publication type:
- Article
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.
- Published in:
- Parasitology Research, 2021, v. 120, n. 12, p. 4037, doi. 10.1007/s00436-021-07342-1
- By:
- Publication type:
- Article
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
- Published in:
- Parasitology Research, 2021, v. 120, n. 1, p. 321, doi. 10.1007/s00436-020-06971-2
- By:
- Publication type:
- Article
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells.
- Published in:
- Parasitology Research, 2020, v. 119, n. 8, p. 2609, doi. 10.1007/s00436-020-06752-x
- By:
- Publication type:
- Article
Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis.
- Published in:
- Pathogens, 2023, v. 12, n. 2, p. 314, doi. 10.3390/pathogens12020314
- By:
- Publication type:
- Article
Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis.
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 6, p. 851, doi. 10.3390/biology12060851
- By:
- Publication type:
- Article
A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-31382-5
- By:
- Publication type:
- Article
B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from Patients.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 9, p. 1877, doi. 10.3390/v15091877
- By:
- Publication type:
- Article